Gale therapy for osteoarthritis

骨关节炎的大风疗法

基本信息

  • 批准号:
    15591585
  • 负责人:
  • 金额:
    $ 2.3万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2003
  • 资助国家:
    日本
  • 起止时间:
    2003 至 2004
  • 项目状态:
    已结题

项目摘要

1.To determine the therapeutic effect of IL-4 mediated adenovirus vector on the murine osteoarthritis model, AdCIL4 was administrated to the male 16-week-old SRT/ort mice intravenously. It was observed that knee joints form the mice to which injected with AdCIL4 showed significantly inhibited to affect with osteoarthritic changes compared with those of control mice. Although there was the problem to induce the inflammation by AdCIL4, it seemed that local administration with vectors could be a therapeutic method for osteochondral lesion.2.To examine the effect of IL-4 on matrix synthesis in chondrocytes under excessive mechanical stress in vitro. Mechanical stress for 16 hours significantly decreased levels of mRNA for both AGG and CII (p<0.01), but rat IL-4 at doses of 1 or 10 ng/ml recovered these levels (p<0.05).These findings suggested that IL-4 might prevent articular cartilage from damage caused by mechanical stress and therefore could be a useful therapeutic agent for treatment of arthritic disorders.
1.为探讨IL-4腺病毒载体对小鼠骨关节炎模型的治疗作用,将AdCIL-4静脉注射给16周龄雄性SRT/ort小鼠。观察到,与对照小鼠相比,注射AdCIL 4的小鼠的膝关节显示出对骨关节炎变化的显著抑制作用。虽然AdCIL-4在诱导炎症反应方面存在一定的问题,但局部给药有望成为治疗骨软骨损伤的一种方法。2.研究IL-4对体外培养的软骨细胞在过度机械应力下基质合成的影响。机械应力作用16小时后,AGG和CII的mRNA水平均显著降低(p<0.01),而IL-4在1和10 ng/ml剂量下可使AGG和CII的mRNA水平恢复(p<0.05)。

项目成果

期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Interleukin-4 protects matrix synthesis in chondrocytes under excessive mechanical stress in vitro.
Interleukin-4 在体外过度机械应力下保护软骨细胞的基质合成。
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    A.Shimizu;S.Watanabe;S.Iimoto;H.Yamamoto
  • 通讯作者:
    H.Yamamoto
Recombinant adeno-associated virus preferentially transduces human, compared to mouse, synovium : implications for arthritis therapy.
与小鼠相比,重组腺相关病毒优先转导人类滑膜:对关节炎治疗的影响。
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Shigeki Katakura;Kristi Jennings;Shohei Watanabe;et al.
  • 通讯作者:
    et al.
Interleukin-4 protects matrix synthesis in chondrocytes under excessive mechanical stress in vitro
Interleukin-4 在体外过度机械应力下保护软骨细胞的基质合成
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Akira Shimizu;Shohei Watanabe;Seiji Iimoto;et al.
  • 通讯作者:
    et al.
Recombinant adeno-associated virus preferentially transduces human, compared to mouse, synovium : implications for arthritis ther
与小鼠滑膜相比,重组腺相关病毒优先转导人类滑膜:对关节炎的影响
  • DOI:
  • 发表时间:
    2004
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Shigeki Katakura;Kristi Jennings;Shohei Watanabe;et al.
  • 通讯作者:
    et al.
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

WATANABE Shohei其他文献

WATANABE Shohei的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('WATANABE Shohei', 18)}}的其他基金

The reserch on effective career education using group career counseling techniques
利用团体职业咨询技术进行有效职业教育的研究
  • 批准号:
    19K02842
  • 财政年份:
    2019
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Gene therapy for osteochondral defect
骨软骨缺损的基因治疗
  • 批准号:
    13671516
  • 财政年份:
    2001
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Developing new tests and treatments to enable prevention of osteoarthritis.
开发新的测试和治疗方法以预防骨关节炎。
  • 批准号:
    MR/Y003470/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Fellowship
Repurposing Alpha-1-antitrypsin as a treatment for post-traumatic osteoarthritis
重新利用 Alpha-1-抗胰蛋白酶治疗创伤后骨关节炎
  • 批准号:
    MR/Y013883/1
  • 财政年份:
    2024
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Research Grant
Pathophysiology of osteoarthritis focusing on transcriptional enhancers from GWAS and single cell RNAseq analysis
骨关节炎的病理生理学重点关注 GWAS 和单细胞 RNAseq 分析中的转录增强子
  • 批准号:
    23K08697
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Does BMI miss the mark? Use of an abdominal obesity index in osteoarthritis
BMI 是否达标?
  • 批准号:
    499189
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Operating Grants
Contribution of synovial fibroblast cell subsets to the pathogenesis of knee osteoarthritis
滑膜成纤维细胞亚群对膝骨关节炎发病机制的贡献
  • 批准号:
    479219
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Operating Grants
Developing a gait-based system to detect early knee osteoarthritis.
开发基于步态的系统来检测早期膝骨关节炎。
  • 批准号:
    23K16633
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
A machine learning model to assess the presence and severity of knee osteoarthritis based on gait data features
基于步态数据特征评估膝骨关节炎的存在和严重程度的机器学习模型
  • 批准号:
    23K16611
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
The development of novel disease-modifying osteoarthritis drug candidate targeting supersulphides
针对超硫化物的新型缓解骨关节炎候选药物的开发
  • 批准号:
    23K19677
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Development of Drugs for Temporomandibular Joint Osteoarthritis Using Dental Pulp Stem Cells
利用牙髓干细胞开发治疗颞下颌关节骨关节炎的药物
  • 批准号:
    23K19746
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Morphologic and Kinematic Adaptations of the Subtalar Joint after Ankle Fusion Surgery in Patients with Varus-type Ankle Osteoarthritis
内翻型踝骨关节炎患者踝关节融合手术后距下关节的形态和运动学适应
  • 批准号:
    10725811
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了